Skip to main content
. 2014 Jun;43(6):800–808.

Table 1.

Univariate analysis of Risk factors

Risk factor No. of Patient (%) Median Survival Time(Month) Log-Rank Test P-value
Sex 0.35 0.870
Male 228(69.1) 20.81
Female 102(30.9) 17.83
Age 40.81 <0.001
<61 87(26.36) 29.97
61-70 123(37.27) 23.66
>70 120(36.36) 12.36
Marital Status 3.64 0.056
Married 315(95.45) 18.70
Single 15(4.55) 68.23
Smoking History 0.18 0.668
NO 230(69.70) 21.27
Yes 100(30.30) 18.30
Tumor Location 2.66 0.264
Cardia 145(43.94) 16
Anterior 63(19.09) 23.9
Other 122(36.97) 21.5
Pathology 1.07 0.300
Adenocarcinoma 281(85.15) 18.70
Other* 49(14.85) 23.14
Metastases 6.36 0.012
Negative 138(41.82) 22.37
Positive 192(58.18) 16.90
Location of Metastases 2.34 0.310
Lymph 128(66.67) 16.90
Liver 24(12.50) 17.30
Other** 40(20.83) 16.33
Lymph node Metastases 1.03 0.310
Negative 187(56.67) 20.81
Positive 143(43.33) 17.53
Liver Metastases 1.52 0.217
Negative 306(92.73) 19.27
Positive 24(7.27) 17.30
Distance Metastases 4.47 0.035
Negative 287(86.97) 20.70
Positive 43(13.03) 16.33
Relapse 1.97 0.161
No 287(86.97) 19.00
Yes 43(13.03) 17.77
Stage 10.34 0.016
I 22(6.67) 29.10
II 60(18.18) 25
III 54(16.36) 13.36
IV 194(58.79) 17.30
Number of Renewed Treatment 57.48 <0.001
0 67(20.30) 5.00
1 76(23.03) 12.53
2 101(30.61) 23.54
3 86(26.06) 33.47
Type of Gastrectomy 2.18 0.702
Total 173(52.42) 18.70
Subtotal 90(27.27) 17.00
Distal 10(3.03) 43.17
Partial 29(8.79) 19.00
Proximal 28(8.48) 24.67

* Squamous cell carcinoma (SCC), small-cell carcinoma, carcinoid tumor, spindle cell tumor, sarcoma, malignant lymphoma./** Diaphragm, spleen, pancreas, lungs, bone